Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Jeet will be a trusted partner in cardiovascular care
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Subscribe To Our Newsletter & Stay Updated